As a Canadian-owned company, we understand the specific needs of Canadian researchers and offer 2-4 day delivery throughout the country with price matching to ensure competitive value

Risk Factors for Adverse Reactions Some individuals may be at higher risk for side effects, and therefore, we recommend that you speak to a medical professional if you have any of the following: Pre-existing liver or kidney conditions Autoimmune disorders Hormone-sensitive conditions History of allergic reactions to peptides Long-Term Safety Considerations Its important to note several key facts about long-term safety: No human clinical trials have assessed long-term safety beyond several months Carcinogenicity (cancer-causing potential) has not been thoroughly studied The potential for developing antibodies against BPC 157 with prolonged use is unknown Possible tolerance development with continuous use has not been well-researched Long-term effects on hormone systems remain unclear Extent of Research on BPC 157 As it stands, BPC 157 still has some research gaps
Conclusion BPC-157, TB-500, and GHK-Cu each deliver powerfulbut distincthealing benefits
protect from light and avoid freezethaw cycles
One phase 3 clinical trial found that survodutide led to an average 12% to 18.7% body weight reduction , depending on dose, in adults with obesity and without diabetes after 76 weeks compared to 5% in the placebo group